A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
about
Oligonucleotide therapeutic approaches for Huntington diseaseHuntingtin in health and diseaseEvidence-based guideline: pharmacologic treatment of chorea in Huntington disease: report of the guideline development subcommittee of the American Academy of NeurologyMetabolism in HD: still a relevant mechanism?A water soluble CoQ10 formulation improves intracellular distribution and promotes mitochondrial respiration in cultured cellsComprehensive behavioral testing in the R6/2 mouse model of Huntington's disease shows no benefit from CoQ10 or minocyclineCoenzyme Q10 and Neurological Diseases.Sex-dependent changes in social behaviors in motor pre-symptomatic R6/1 mice.Tetrabenazine as anti-chorea therapy in Huntington disease: an open-label continuation study. Huntington Study Group/TETRA-HD Investigators.Potential future neuroprotective therapies for neurodegenerative disorders and stroke.The relationship between uric acid levels and Huntington's disease progressionTherapeutic Strategies in Huntington's DiseaseCombination therapy with coenzyme Q10 and creatine produces additive neuroprotective effects in models of Parkinson's and Huntington's diseases.Advocacy Recruiting for Huntington's Disease Clinical TrialsPlasma 8-hydroxy-2'-deoxyguanosine Levels in Huntington Disease and Healthy Controls Treated with Coenzyme Q10Triterpenoids CDDO-ethyl amide and CDDO-trifluoroethyl amide improve the behavioral phenotype and brain pathology in a transgenic mouse model of Huntington's diseaseChorea and related disorders.Current experience in testing mitochondrial nutrients in disorders featuring oxidative stress and mitochondrial dysfunction: rational design of chemoprevention trials.Why are there no proven therapies for genetic mitochondrial diseases?Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study.The Current Status of Neural Grafting in the Treatment of Huntington's Disease. A ReviewCoenzyme Q10 decreases amyloid pathology and improves behavior in a transgenic mouse model of Alzheimer's disease.Cardiac dysfunction in the R6/2 mouse model of Huntington's diseaseEvidence for behavioral benefits of early dietary supplementation with CoEnzymeQ10 in a slowly progressing mouse model of Huntington's disease.Oral repeated-dose toxicity studies of coenzyme Q10 in beagle dogs.Latrepirdine, a potential novel treatment for Alzheimer's disease and Huntington's chorea.The paradigm of Huntington's disease: therapeutic opportunities in neurodegeneration.Translating therapies for Huntington's disease from genetic animal models to clinical trials.Evidence from biomarkers and surrogate endpoints.Dithiol-based compounds maintain expression of antioxidant protein peroxiredoxin 1 that counteracts toxicity of mutant huntingtin.The use of the R6 transgenic mouse models of Huntington's disease in attempts to develop novel therapeutic strategies.A randomized, double-blind, placebo-controlled study of oral coenzyme Q10 to relieve self-reported treatment-related fatigue in newly diagnosed patients with breast cancerRefining the diagnosis of Huntington disease: the PREDICT-HD study.Coenzyme Q10 levels are low and associated with increased mortality in post-cardiac arrest patientsA pilot assessment of parental practices and attitudes regarding risk disclosure and clinical research involving children in Huntington disease families.Symptomatic treatment of Huntington diseaseNeuroprotection for Huntington's disease: ready, set, slowAntioxidants in central nervous system diseases: preclinical promise and translational challenges.Mitochondrial approaches for neuroprotectionCoenzyme Q10 effects in neurodegenerative disease.
P2860
Q22306293-0EE8DF46-1868-42E8-B179-140F5FAB2229Q24554374-DE8D27A2-71C8-4D6D-8D6F-C9FC854B69D3Q24621818-FF640DD1-B7E6-4BEA-BCC3-EC1223B8A6BFQ28394301-438D14EA-41E4-4D0C-AFFF-9037B3990708Q28481504-6CCB6B04-A451-42D4-9B50-1CB886BEF29DQ28748449-66B5B137-0405-4DA1-928E-6E3E95E6F51AQ30440307-08191A0E-12AE-4577-9D12-1E84D8DF9D15Q30475466-95D1F326-B5C7-460F-851A-CD1EA1C60868Q33519733-A311F06C-AC13-4FED-B87B-FB41144474D0Q33687436-90F6E5CC-6574-47AE-BFD9-7F3ABC009B98Q33699054-83C0B192-39C7-4214-81AA-CC24229007DFQ33790829-A3941599-1160-42EF-9A22-57A8253CE9D9Q33837238-4F186267-1F30-4D9F-A08A-CD43335BC2B7Q33885904-19F11F22-20C6-4EC6-B4C9-BB67DE58966AQ33970690-4A6611B9-08F4-4425-B741-AE1BE78932AFQ34043950-585B9863-42CC-4C0E-85F2-243DBB09225DQ34346879-3C8FF5DD-D677-4877-B2FA-83521A871B16Q34685307-8047F175-824A-497B-B684-AEEE78D78C1FQ35162928-1B6AA4AE-B168-4999-87EE-69E5BB860791Q35487438-D9AC9D10-EAE4-4992-934C-703165A02373Q35597607-3E24B042-114A-427D-B5B1-A902B24DC673Q35706496-33D1EC3C-3FB2-474D-BEA4-4ED4025EA1D6Q35745626-C1D3D166-4B85-4F80-8EF8-294D898D6506Q35754248-DC5E0108-6447-4F2E-B1E3-3B70D69A92DDQ35783279-0470025A-DE10-46A2-A7E6-A6A83599F664Q35940409-5623F071-8889-44BD-BDCE-DE32759A3196Q36045254-52354C3B-0440-44E4-B593-2C84BDC57D7CQ36045315-A24211AC-911F-43CF-99CE-B8B359BD99D0Q36045330-E644DDE9-DA0D-4DC5-B47F-BD1E7010D8EEQ36080317-6B70E36D-04D0-40BE-A201-F4F31A3246E7Q36358871-94324F56-403D-40B6-B1EC-597B87B93B74Q36409534-32919B46-AD08-4FC5-8BDA-5B1C7C0AA78CQ36732557-A2291011-6042-4B42-BBE2-DEC398FA98A0Q36856037-64BC347D-1C11-4D0C-B0B1-3876E8EF290BQ37002400-A1B00C93-C193-4EB1-B9D2-E6199F6DCC46Q37131233-D5B27DFA-5993-4C4C-80A3-AB074FE7166EQ37131243-BFD45DC8-B6C3-4FF1-B774-B601F11AB235Q37159979-B190E77F-C4A9-4E26-9773-76ACA2D02733Q37348590-04B33B0C-A284-4E67-A8F5-7FD472209808Q37448888-AA348B7B-DD9B-4733-AF13-6E3CFA10588C
P2860
A randomized, placebo-controlled trial of coenzyme Q10 and remacemide in Huntington's disease.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
A randomized, placebo-controll ...... emide in Huntington's disease.
@en
A randomized, placebo-controll ...... emide in Huntington's disease.
@nl
type
label
A randomized, placebo-controll ...... emide in Huntington's disease.
@en
A randomized, placebo-controll ...... emide in Huntington's disease.
@nl
prefLabel
A randomized, placebo-controll ...... emide in Huntington's disease.
@en
A randomized, placebo-controll ...... emide in Huntington's disease.
@nl
P921
P1433
P1476
A randomized, placebo-controll ...... emide in Huntington's disease.
@en
P2093
Huntington Study Group
P304
P407
P577
2001-08-01T00:00:00Z